| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.001 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |